Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations

Abstract

Background: Early-onset Parkinson's disease (EOPD)/young-onset Parkinson's disease (YOPD) is defined as Parkinson's disease (PD) with an age at onset (AAO) after age 21 years but before the usual AAO for PD. Consensus is lacking, and the reported maximal age for EOPD/YOPD has varied from 40 to 60 years, leading to a lack of uniformity in published studies and difficulty in harmonization of data. EOPD and YOPD have both been used in the literature, somewhat interchangeably. Objective: To define the nomenclature and AAO cutoff for EOPD/YOPD. Methods: An extensive review of the literature and task force meetings were conducted. Conclusions were reached by consensus. Results: First, the literature has seen a shift from the use of YOPD toward EOPD. This seems motivated by an attempt to avoid age-related stigmatization of patients. Second, in defining EOPD, 56% of the countries use 50 or 51 years as the cutoff age. Third, the majority of international genetic studies in PD use an age cutoff of younger than 50 years to define EOPD. Fourth, many studies suggest that changes in the estrogen level can affect the predisposition to develop PD, making the average age at menopause of 50 years an important factor to consider when defining EOPD. Fifth, considering the differential impact of the AAO of PD on professional and social life, using 50 years as the upper cutoff for the definition of EOPD seems reasonable. Conclusions: This task force recommends the use of EOPD rather than YOPD. It defines EOPD as PD with AAO after 21 years but before 50 years.

Original languageEnglish
Pages (from-to)869-878
Number of pages10
JournalMovement Disorders Clinical Practice
Volume9
Issue number7
DOIs
StatePublished - Oct 2022

Funding

FundersFunder number
AbbVie Pty Ltd
Early Onset Parkinson Disease Task Force
MSCE
Paul Ainsworth Family Foundation
Rush University Center for Excellence in Aging
Setsuro Fujii Memorial Foundation
National Institute on Aging5P30AG064200‐02
National Institute of Neurological Disorders and Stroke5U01NS100610‐05/737SUB U01NS100610, 1K23NS097615‐01A1
Michael J. Fox Foundation for Parkinson's Research
Mayo Clinic
Patient-Centered Outcomes Research Institute
Takeda Pharmaceuticals U.S.A.
Rush University
Japan Agency for Medical Research and Development20dm0107156, 21wm0425015, 21ak0101112, 21dk0207055
Parkinson's FoundationPF‐CORE‐856255, PF‐COE‐PC‐920660
ACADIA Pharmaceuticals
Kyowa Kirin Pharmaceutical Development
National Medical Research Council
Japan Society for the Promotion of Science21K07424
Daiichi-Sankyo
Dainippon Sumitomo Pharma
Otsuka Pharmaceutical
FP Pharmaceutical Corporation

    Keywords

    • Parkinson's disease
    • age cutoff
    • early onset
    • young onset

    Fingerprint

    Dive into the research topics of 'Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease'. Together they form a unique fingerprint.

    Cite this